InvestorsHub Logo
Post# of 252527
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 88651

Friday, 01/08/2010 9:26:16 AM

Friday, January 08, 2010 9:26:16 AM

Post# of 252527
If it's a safer beta blocker it would make a good candidate for higher-risk hypertension patients (diabetes, obesity, CHF, COPD) and that's what FRX is trying to prove in many ongoing phase IV trials for Bystolic.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.